Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation
2011
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Simultaneous Activity of MRP1 and Pgp Is Correlated With In Vitro Resistance to Daunorubicin and With In Vivo Resistance in Adult Acute Myeloid Leukemia
1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins
2000
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
2002
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer
2000
P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications
1999
Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
2007
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
2001
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
P‐glycoprotein (PGP), lung resistance‐related protein (LRP) and multidrug resistance‐associated protein (MRP) expression in acute promyelocytic leukaemia
2000
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
1998
Vaults: a ribonucleoprotein particle involved in drug resistance?
2003
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
2001 Standout
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Risk assessment in haemotopoietic stem cell transplantation: Disease and disease stage
2007
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
1999 Standout
Dose Intensification of Etoposide in the BEAM ABMT Protocol for Malignant Lymphoma
1995
Thrombotic Microangiopathy after Allogeneic Blood and Marrow Transplantation Is Associated with Dose-Intensive Myeloablative Conditioning Regimens, Unrelated Donor, and Methylprednisolone T-Cell Depletion
2004
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Multiple myeloma
2000 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Genomic Variation of Human Papillomavirus Type 16 and Risk for High Grade Cervical Intraepithelial Neoplasia
1997
Chronic graft-versus-host disease
2003 Standout
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus
2006
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992
Targeting multidrug resistance in cancer
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Biology and management of relapsed acute myeloid leukaemia
2005
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis
2005
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
2004
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
2000
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Protective and pathogenic functions of macrophage subsets
2011 Standout
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:
2004
Acute Myeloid Leukemia
1999
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
1993
Diffuse large B-cell lymphoma
2013
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
2012 Standout
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Structure of the vault, a ubiquitous celular component
1999
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
The Role of ABC Transporters in Clinical Practice
2003
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
1997
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
1994
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Acute Myeloid Leukemia
2015 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
TELOMERES AND THEIR CONTROL
2000 StandoutNobel
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
2000
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein
2004
Biology of Gastrointestinal Stromal Tumors
2004 Standout
FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors
1996
Primary dexamethasone treatment of multiple myeloma
1992
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
2014
New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
2004
Mechanisms of Cancer Drug Resistance
2002 Standout
Identification of Pancreatic Cancer Stem Cells
2007 Standout
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
1993
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
2005
Diffuse large cell lymphoma
2011
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group
2003
Multidrug resistance in human tumors—molecular diagnosis and clinical significance
1999
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
1990
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
2004
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
2001
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
1986
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia
2005
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
1996
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
2013
Works of SN Wolff being referenced
Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma
2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
2000
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
1990
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study
1985
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation
1989
High-dose cytosine arabinoside therapy for refractory leukemia
1983
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group
1995
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
1996
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
1990